Skip to main content
. Author manuscript; available in PMC: 2014 Jan 6.
Published in final edited form as: Diabetologia. 2011 Aug 18;54(11):10.1007/s00125-011-2271-9. doi: 10.1007/s00125-011-2271-9

Fig. 3.

Fig. 3

Insulin-resistant IRS-1 phosphorylation sites in type 2 diabetic muscle in vivo. Experiments were performed identically with those described in Fig. 1. *p≤0.05; **p≤0.01; effect of insulin compared with the −60 min time point, within group; t test. T2D, type 2 diabetes

HHS Vulnerability Disclosure